5.4 Gene therapy: targeting underlying molecular defects Gene therapy in PD aims to: Restore dopamine synthesis: e.g., via delivery of aromatic L-amino acid decarboxylase (AADC)
The metered spray delivery system allows researchers to administer controlled quantities during experimental applications where precise measurement is required
PubMed 7(6):456 Prez OMM, Flrez-Vargas O, Cruz GR, Gonzlez FR, Rocha-Muoz LP, Rodrguez LHS (2021) Glutathione-related genetic polymorphisms are associated with mercury retention and nephrotoxicity in gold-mining settings of a colombian population
Additionally, PARP inhibitors (PARPi) demonstrate significant clinical efficacy in BRCA-mutated patients (124), but emerging resistance limits their long-term effectiveness (125), Patients may develop resistance through multiple mechanisms, such as secondary BRCA gene mutations or restoration of DNA repair pathways (126)
(2016) 113(34):E496675
FOXO4-DRI Peptide (Lyophilized)